| The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management MY Abou-Ismail, A Diamond, S Kapoor, Y Arafah, L Nayak Thrombosis research 194, 101-115, 2020 | 697 | 2020 |
| Estrogen and thrombosis: a bench to bedside review MY Abou-Ismail, DC Sridhar, L Nayak Thrombosis research 192, 40-51, 2020 | 130 | 2020 |
| Central venous catheter-related thrombosis in children and adults DC Sridhar, MY Abou-Ismail, SP Ahuja Thrombosis research 187, 103-112, 2020 | 118 | 2020 |
| Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT AJ Kanack, A Bayas, G George, MY Abou-Ismail, B Singh, MC Kohlhagen, ... Blood, The Journal of the American Society of Hematology 140 (1), 73-77, 2022 | 36 | 2022 |
| Persistence of Ad26. COV2. S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies AJ Kanack, B Singh, G George, K Gundabolu, SA Koepsell, ... American journal of hematology 97 (5), 519-526, 2022 | 30 | 2022 |
| Vaccine‐induced thrombotic thrombocytopenia following Ad26. COV2. S vaccine in a man presenting as acute venous thromboembolism MY Abou‐Ismail, KA Moser, KJ Smock, MY Lim American Journal of Hematology 96 (9), E346, 2021 | 28 | 2021 |
| Off‐label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: a scoping review of the literature VM Thomas, MY Abou‐Ismail, MY Lim Haemophilia 28 (1), 4-17, 2022 | 27 | 2022 |
| Acquired von Willebrand syndrome in monoclonal gammopathy–A scoping review on hemostatic management MY Abou‐Ismail, GM Rodgers, PF Bray, MY Lim Research and practice in thrombosis and haemostasis 5 (2), 356-365, 2021 | 22 | 2021 |
| Outgrowing the laboratory diagnosis of type 1 von W illebrand disease: A two decade study MY Abou‐Ismail, GO Ogunbayo, M Secic, PA Kouides American Journal of Hematology 93 (2), 232-237, 2018 | 20 | 2018 |
| Thrombotic microangiopathies: an illustrated review MY Abou‐Ismail, S Kapoor, D Citla Sridhar, L Nayak, S Ahuja Research and Practice in Thrombosis and Haemostasis 6 (3), e12708, 2022 | 16 | 2022 |
| Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin B Singh, A Kanack, A Bayas, G George, MY Abou-Ismail, M Kohlhagen, ... medRxiv, 2021 | 15 | 2021 |
| Outcomes of immune thrombotic thrombocytopenic purpura (iTTP) with upfront cyclophosphamide vs. rituximab MY Abou-Ismail, Y Arafah, P Fu, S Cao, AH Schmaier, L Nayak Frontiers in medicine 7, 588526, 2020 | 10 | 2020 |
| Left atrial appendage occlusion for management of atrial fibrillation in persons with hemophilia MY Lim, MY Abou-Ismail Thrombosis research 206, 9-13, 2021 | 8 | 2021 |
| Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies AJ Kanack, CG Jones, B Singh, RR Leger, NP Splinter, NM Heikal, ... Blood, The Journal of the American Society of Hematology 140 (25), 2722-2729, 2022 | 7 | 2022 |
| Mortality in acute immune-mediated thrombotic thrombocytopenic purpura (iTTP) is unpredictable: poor statistical performance of mortality prediction models MY Abou-Ismail, C Zhang, A Presson, M Mazepa, MY Lim, ... Blood 138, 771, 2021 | 7 | 2021 |
| Short term efficacy of recombinant porcine factor VIII in patients with factor VIII inhibitors MY Abou‐Ismail, S Vuyyala, J Prunty, AH Schmaier, L Nayak Haemophilia 26 (4), 601-606, 2020 | 7 | 2020 |
| Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum MY Lim, MY Abou-Ismail, DW Branch Obstetrics & Gynecology 141 (1), 85-108, 2023 | 6 | 2023 |
| Beyond the guidelines: how we approach challenging scenarios in the diagnosis and management of von Willebrand disease MY Abou-Ismail, PD James, VH Flood, NT Connell Journal of Thrombosis and Haemostasis 21 (2), 204-214, 2023 | 4 | 2023 |
| Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation? MY Abou‐Ismail, R Fraser, M Allbee‐Johnson, L Metheny III, G Ravi, ... British journal of haematology 197 (3), 326-338, 2022 | 4 | 2022 |
| Corrigendum to “The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management”[Thromb. Res., 194, October 2020, Pages 101–115] MY Abou-Ismail, A Diamond, S Kapoor, Y Arafah, L Nayak Thrombosis Research 204, 146, 2021 | 4 | 2021 |
